Drugs / PD01A
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02270489 | Dec 2014 → Apr 2017 | multiple system atrophy | Affiris AG | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PD01A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02270489 ↗ |
| Modality | Vaccine | “PD01A and PD03A are 2 novel therapeutic vaccine candidates containing short peptides as antigenic moieties” PMID 32882100 ↗ Sep 2020 |
| Route | Subcutaneous | “receive 5 subcutaneous injections of either PD01A (n = 12), PD03A (n = 12), or placebo (n = 6)” PMID 32882100 ↗ Sep 2020 |